20Slash20 Inc., the creator of The Eye Drink, announced today that it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu is set to deliver an investor presentation at 9:35 a.m. ET on Sept. 9 at The Westin New York Grand Central, followed by one-on-one meetings with investors. The conference aims to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors.
The company’s flagship product, The Eye Drink, is described as the world’s first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health, particularly for individuals who spend extended hours on phones and computers. With the increasing prevalence of digital screens in daily life, the demand for products that address screen-induced eye problems is growing. According to the press release, The Eye Drink offers a convenient and tasty solution to support eye health in today’s screen-centric world.
The conference provides a platform for 20Slash20 to present its value proposition to investors and industry professionals, potentially increasing its visibility in the functional beverage market. The event, hosted by Moody Capital Solutions, is designed to highlight disruptive growth opportunities, making it a key venue for companies like 20Slash20 to attract investment and forge strategic partnerships.
The announcement underscores the importance of eye health in the digital age, as more people experience symptoms such as eye strain, dryness, and fatigue due to prolonged screen use. By positioning The Eye Drink as a preventive measure, 20Slash20 aims to capitalize on a growing consumer awareness of wellness and health optimization. The company’s participation in the conference signals its commitment to scaling its operations and expanding its market reach.
The conference also offers a chance for investors to evaluate emerging companies in the life sciences and wellness sectors, which have seen increased interest amid a global focus on health and technology integration. 20Slash20’s innovative approach to addressing a widespread issue could resonate with investors looking for novel solutions with commercial potential.
For more information about the conference or 20Slash20, interested parties can refer to the full press release at https://ibn.fm/tm2lT. Additional details about the company and its products are available through its official communications channels.
